Tsang-A-Sjoe MW - Search Results

1

Fc-gamma receptor polymorphisms differentially influence susceptibility to systemic lupus erythematosus and lupus nephritis.

Tsang-A-Sjoe MW, Nagelkerke SQ, Bultink IE, Geissler J, Tanck MW, Tacke CE, Ellis JA, Zenz W, Bijl M, Berden JH, de Leeuw K, Derksen RH, Kuijpers TW, Voskuyl AE. Tsang-A-Sjoe MW, et al. Rheumatology (Oxford). 2016 May;55(5):939-48. doi: 10.1093/rheumatology/kev433. Epub 2016 Jan 8. Rheumatology (Oxford). 2016. PMID: 26748351

2

Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus.

Tsang-A-Sjoe MW, Bultink IE, Heslinga M, Voskuyl AE. Tsang-A-Sjoe MW, et al. Rheumatology (Oxford). 2017 Jan;56(1):121-128. doi: 10.1093/rheumatology/kew377. Epub 2016 Nov 1. Rheumatology (Oxford). 2017. PMID: 27803306

3

New developments in systemic lupus erythematosus.

Tsang-A-Sjoe MWP, Bultink IEM. Tsang-A-Sjoe MWP, et al. Rheumatology (Oxford). 2021 Dec 24;60(Suppl 6):vi21-vi28. doi: 10.1093/rheumatology/keab498. Rheumatology (Oxford). 2021. PMID: 34951924 Free PMC article. Review.

4

The relationship between remission and health-related quality of life in a cohort of SLE patients.

Tsang-A-Sjoe MWP, Bultink IEM, Heslinga M, van Tuyl LH, van Vollenhoven RF, Voskuyl AE. Tsang-A-Sjoe MWP, et al. Rheumatology (Oxford). 2019 Apr 1;58(4):628-635. doi: 10.1093/rheumatology/key349. Rheumatology (Oxford). 2019. PMID: 30517706

5

Systemic lupus erythematosus: review of synthetic drugs.

Tsang-A-Sjoe MW, Bultink IE. Tsang-A-Sjoe MW, et al. Expert Opin Pharmacother. 2015;16(18):2793-806. doi: 10.1517/14656566.2015.1101448. Epub 2015 Oct 19. Expert Opin Pharmacother. 2015. PMID: 26479437 Review.

6

Comprehensive approach to study complement C4 in systemic lupus erythematosus: Gene polymorphisms, protein levels and functional activity.

Tsang-A-Sjoe MWP, Bultink IEM, Korswagen LA, van der Horst A, Rensink I, de Boer M, Hamann D, Voskuyl AE, Wouters D. Tsang-A-Sjoe MWP, et al. Mol Immunol. 2017 Dec;92:125-131. doi: 10.1016/j.molimm.2017.10.004. Epub 2017 Oct 26. Mol Immunol. 2017. PMID: 29080553 Clinical Trial.

7

Long-term evaluation of antimalarials in a Dutch SLE cohort: intolerance and other reasons for non-use.

Tsang-A-Sjoe MW, Bultink IE, Voskuyl AE. Tsang-A-Sjoe MW, et al. Clin Exp Rheumatol. 2014 Jan-Feb;32(1):95-100. Epub 2013 Nov 14. Clin Exp Rheumatol. 2014. PMID: 24238093

8

Anti-Hinge Antibodies Recognize IgG Subclass- and Protease-Restricted Neoepitopes.

Falkenburg WJ, van Schaardenburg D, Ooijevaar-de Heer P, Tsang-A-Sjoe MW, Bultink IE, Voskuyl AE, Bentlage AE, Vidarsson G, Wolbink G, Rispens T. Falkenburg WJ, et al. Among authors: tsang a sjoe mw. J Immunol. 2017 Jan 1;198(1):82-93. doi: 10.4049/jimmunol.1601096. Epub 2016 Nov 18. J Immunol. 2017. PMID: 27864476

9

Macrophages in Lupus Nephritis: Exploring a potential new therapeutic avenue.

Kwant LE, Vegting Y, Tsang-A-Sjoe MWP, Kwakernaak AJ, Vogt L, Voskuyl AE, van Vollenhoven RF, de Winther MPJ, Bemelman FJ, Anders HJ, Hilhorst ML. Kwant LE, et al. Among authors: tsang a sjoe mwp. Autoimmun Rev. 2022 Dec;21(12):103211. doi: 10.1016/j.autrev.2022.103211. Epub 2022 Oct 14. Autoimmun Rev. 2022. PMID: 36252930 Free article. Review.

10

Pharmacodynamic monitoring of (immuno)proteasome inhibition during bortezomib treatment of a critically ill patient with lupus nephritis and myocarditis.

de Groot KA, Tsang A Sjoe M, Niewerth D, Cloos J, Blank JL, Niessen HW, Zweegman S, Voskuyl AE, Jansen G, van der Heijden JW. de Groot KA, et al. Lupus Sci Med. 2015 Dec 18;2(1):e000121. doi: 10.1136/lupus-2015-000121. eCollection 2015. Lupus Sci Med. 2015. PMID: 26719810 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page